Guardant Health insider disposals: 580 shares reported

Guardant Health (GH) notice of proposed insider sales by Musa Tariq.

Rhea-AI Filing Summary

Guardant Health (GH) notice of proposed insider sales by Musa Tariq. The filing lists prior sales of common stock in three separate transactions: 03/18/2026 — 348 shares (aggregate $30,655), 04/16/2026 — 116 shares (aggregate $9,840), and 05/18/2026 — 116 shares (aggregate $11,131).

The filing also records a restricted stock lapse on 06/15/2026 associated with equity compensation and lists brokerage details for Charles Schwab & Co. The notice records proposed sale activity under Form 144; timing and method of any future sales are not detailed beyond the listed items.

Insights

Securities Compliance Counsel

Routine Form 144 notice showing small insider dispositions tied to equity compensation.

Form 144 is a regulatory notice required for certain proposed sales by affiliates. The filing lists three recent dispositions totaling 580 shares across March–May 2026 and notes a restricted stock lapse dated 06/15/2026 tied to equity compensation.

These quantities are modest in isolation; cash‑flow treatment and any planned future sales are not described in the excerpt. Subsequent public filings would show whether further transactions occur under the notice.

Key Figures

Disposition 1: 348 shares Disposition 2: 116 shares Disposition 3: 116 shares +1 more

4 metrics

Disposition 1 348 shares 03/18/2026, aggregate $30,655

Disposition 2 116 shares 04/16/2026, aggregate $9,840

Disposition 3 116 shares 05/18/2026, aggregate $11,131

Restricted stock lapse event dated 06/15/2026 Listed as 'Restricted Stock Lapse' under Securities To Be Sold

Key Terms

Form 144, Restricted Stock Lapse, Equity Compensation

3 terms

Form 144 regulatory

"144: Securities Sold During The Past 3 Months"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Lapse financial

"Securities To Be Sold | 06/15/2026 | Restricted Stock Lapse"

Equity Compensation financial

"06/15/2026 | Equity Compensation"

Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Guardant Health's (GH) Form 144 filed for Musa Tariq show?

It shows proposed insider sale activity and recent dispositions by Musa Tariq. The filing lists three past dispositions: 348 shares ($30,655), 116 shares ($9,840), and 116 shares ($11,131) on March, April, and May 2026 respectively.

Were any restricted shares or equity compensation events disclosed in the GH Form 144?

Yes. The filing records a restricted stock lapse dated 06/15/2026 tied to equity compensation. The entry names Guardant Health and records the lapse as the security event.

Does the Form 144 state how future sales will be executed for GH shares?

No. The excerpt lists past dispositions and a restricted stock lapse but does not describe the timing, method, or broker instructions for any future sales beyond brokerage identification for Charles Schwab & Co.

How many shares did Musa Tariq dispose of in the past three months according to the filing?

The filing lists three dispositions totaling 580 shares: 348 shares on 03/18/2026, 116 shares on 04/16/2026, and 116 shares on 05/18/2026, with aggregate amounts shown.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/16/2026 - 04:02 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001968281
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Guardant Health, Inc.
SEC File Number	001-38683
Address of Issuer	3100 HANOVER STREET PALO ALTO CALIFORNIA 94304
Phone	855-698-8887
Name of Person for Whose Account the Securities are To Be Sold	Tariq Musa
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	116	15102.00	132599929	06/16/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/15/2026	Restricted Stock Lapse	Guardant Health, Inc.			116	06/15/2026	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Musa Tariq 3100 HANOVER STREET PALO ALTO CA 94304	Guardant Health, Inc.	03/18/2026	348	30655.00
Musa Tariq 3100 HANOVER STREET PALO ALTO CA 94304	Guardant Health, Inc.	04/16/2026	116	9840.00
Musa Tariq 3100 HANOVER STREET, PALO ALTO CA 94304	Guardant Health, Inc.	05/18/2026	116	11131.00

144: Remarks and Signature

Remarks
Date of Notice	06/16/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/17/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Musa Tariq
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)